Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection

Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection: An Open Label Feasibility Study

The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemic.There have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditions.Therefore, present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19

Inclusion Criteria:

• All hospitalised cases above 18 years of age,
• Diagnosed with Covid-19
• Asymptomatic at the time of admission
• Agree to give consent

Exclusion Criteria:

• Symptoms relating to Covid-19
• Severe vomiting
• Respiratory failure or requiring mechanical ventilation
• Patients having alanine transaminase (ALT) or aspartate transaminase (AST) > 5 times the upper range of normal limits
• Patients with Covid-19 in critical condition or ARDS or NIAD 8 -point ordinal score-2
• Patients with uncontrolled diabetes mellitus
• Malignant,
• Chronic renal failure or
• On immunosuppressive medication